Where does Matt Blischak work?

Matt Blischak is Chief Executive Officer at Finch Therapeutics.

Where did Matt Blischak go to school?

Matt Blischak studied at American University Washington College of Law (Doctor of Law (J.D.), Law); The Johns Hopkins University (Master of Science (M.S.), Biotechnology); Case Western Reserve University (Bachelor of Science (B.S.), Chemical Engineering).

Matt Blischak

Chief Executive Officer at Finch Therapeutics

Greater Philadelphia

Find your path to Matt

171 people in our graph share verified history with Matt — schools, employers, funds. One of them is your warm intro.

Tristan HuntunlockedMatt: together at Roivant Sciences (2023)

Matt: together at Roivant Sciences

×10Matt: together at Case Western Reserve University

Chief Executive Officer at Finch Therapeutics

Intro paths

→

In turn, Matt can intro founders to Finch Therapeutics's investors below.

Finch Therapeutics's investors · 6

B3 HoldingPrague · since 2018 HumboldtNew York · $100K – $5M checks · since 2018 Octave Ventures LlcHenderson · since 2018 OCV PartnersLos Angeles · since 2018 OMX VenturesLincolnshire · since 2018 Shumway CapitalGreenwich · since 2018

Co-founders at Finch Therapeutics

Mark SmithExecutive Officer, Director

Experience

Finch TherapeuticsChief Executive Officercurrent2023 — presentGreater Philadelphia
Roivant SciencesVice-President, Intellectual Property Counsel2018 — 2023New York, New York
Teva PharmaceuticalsVice President and General Counsel, Global Specialty IP Litigation2015 — 2018
Teva PharmaceuticalsAssociate General Counsel - Global Branded IP Litigation2013 — 2015Horsham, PA
Teva PharmaceuticalsExecutive Counsel - Global Branded IP Litigation2012 — 2013Horsham, Pa
Sunovion/Sepracor PharmaceuticalsVP Intellectual Property2007 — 2012Marlborough, Massachusetts
Bristol-Myers SquibbSenior Counsel -- Patents, Patent Litigation2000 — 2007Princeton, New Jersey

Skills & more

PatentsPatent LitigationIntellectual PropertyPharmaceutical IndustryBiotechnologyTechnology TransferLicensingPatent ProsecutionPatentabilityLifesciencesBiopharmaceuticalsTrademarks

+5 more

Due DiligenceProsecutionLitigationLife SciencesPatent Law

From Matt's professional profile.

Frequently asked questions

Who is Matt Blischak?: Chief Executive Officer at Finch Therapeutics
Where does Matt Blischak work?: Matt Blischak is Chief Executive Officer at Finch Therapeutics.
Where did Matt Blischak go to school?: Matt Blischak studied at American University Washington College of Law (Doctor of Law (J.D.), Law); The Johns Hopkins University (Master of Science (M.S.), Biotechnology); Case Western Reserve University (Bachelor of Science (B.S.), Chemical Engineering).

Same school

Also attended American University Washington College of Law18

Alexandra Lawrence LaFrankieChief Compliance Officer at EJF Ventures Matthew T. KellyVice President at Venture Justin AntonipillaiVenture Partner at Moonshots Capital Cristina ZuletaDirector, Co-head Sustainability at Magnum Industrial Partners Tres S.L.Scott HershorinCCO at Metastable Tryn StimartCLO, CCO, Compliance Officer, Corporate Secretary & Privacy Officer at AbCellera

+ 12 more

Also attended The Johns Hopkins University538

Dave JohnsonCo-founder & CEO of Dash Bio Nicole GaudelliEntrepreneur in Residence at GV (Google Ventures)Wes NicholsPartner at March Capital Partners Demi ObayomiPrincipal at Sapphire Ventures Jun JeonInvestor at Khosla Ventures Nicole FraenkelInvestor at Khosla Ventures

+ 532 more

Also attended Case Western Reserve University134

Will BruneSenior Associate at Mutual Capital Partners KT MooreAdvisor at Clear Ventures Pete KoomenGeneral Partner at Y Combinator Asheem ChandnaPartner at Greylock focused on enterprise, cybersecurity, and infrastructure software Matt SteinChief Information Officer at Flare Capital Partners Karen SpilizewskiBiomedical engineer helping accelerate life science technologies from development into the marketplace

+ 128 more

Shared employers

Also worked at Finch Therapeutics4

Josh GrehanPartner at Helios Climate Ventures Mark SmithExecutive Officer, Director at Finch Therapeutics Mitch JonesPresident & Chief Medical Officer at Palisadebio Joseph D. VittiglioChief Business & Legal Officer and Secretary at PepGen

Also worked at Roivant Sciences15

Tristan HuntPartner at Averin Capital Eric ThakorVice President at Questa Capital John GlasspoolVenture Partner at Agent Capital Shamillah BankiyaPrincipal at Dawn Capital LLP Wasim MalikManaging Partner at Iaso Ventures Lisa SchechnerInvestor at Commodore Capital

+ 9 more

Also worked at Teva Pharmaceuticals52

Catherine Pearce, DHSc, MBAAdvisor at CincyTech Elad BaronInvestment Professional at Key1 Capital Elaine ShannonPresident, Global Supply & Quality at Takeda Ventures Riki MozesVice President, Chief People Officer at Jerusalem Venture Partners (JVP)Jill DeSimoneDigital Pharma Advisor at Excelerate Health Ventures Perry NisenExecutive Advisor, Private Equity at Sofinnova Ventures

+ 46 more

Also worked at Sunovion/Sepracor Pharmaceuticals15

Kaitlyn LagascaManager, Talent Acquisition at Anzu Partners Dario DollerCo-founder at Modulate Bio Brad NaviaChief Medical Officer at Solaxa Fred GrossmanExecutive Officer at Coya Therapeutics Antony LoebelExecutive Officer at Seaport Therapeutics John CrowleyExecutive Officer at Merus

+ 9 more